Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:32 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2185–2208 of 29,088 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Disease;Neurological Clear all

Conditions: Meningioma, Skull Base Meningioma, Frontal Meningioma, Temporal Meningioma, Cognitive Impairment, Cognitive Decline, Post-Surgical Cognition
Interventions: Long-term Cognitive testing; Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 50 participants
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Parkinson Disease
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 40 Years to 85 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Rheumatoid Arthritis
Interventions: Vegan Diet, dietary supplement omega3 fatty acids aand vitamins; Other · Dietary Supplement
Lead sponsor: Physicians Committee for Responsible Medicine; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: SCI - Spinal Cord Injury
Interventions: The Tethered Pelvic Assist Device (TPAD); Device
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Ovarian Cancer
Interventions: Tuvusertib (M1774), Niraparib, Lartesertib (M4076); Drug
Lead sponsor: EMD Serono Research & Development Institute, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 9
States / cities: Little Rock, Arkansas • San Francisco, California • Columbus, Georgia + 4 more

Conditions: Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia, Paget Disease of Bone, Frontotemporal Dementia, Myopathy
Interventions: Not listed
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2030
U.S. locations: 1
States / cities: Irvine, California

Conditions: Fibromyalgia
Interventions: Digital ACT, Digital Symptom Tracker; Device
Lead sponsor: Swing Therapeutics, Inc.; Other
Eligibility: 22 Years to 75 Years
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 7
States / cities: Oceanside, California • Sacramento, California • Orlando, Florida + 4 more

Conditions: Communication Disorders, Developmental Disabilities
Interventions: Milieu Communication Teaching; Behavioral
Lead sponsor: University of Kansas; Other
Eligibility: 18 Months to 27 Months
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2010
U.S. locations: 2
States / cities: Kansas City, Kansas • Nashville, Tennessee

Conditions: Traumatic Brain Injury
Interventions: Carbamazepine, Placebo; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 16 Years to 75 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Glioblastoma, Gliosarcoma
Interventions: Temozolomide; Drug
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 70 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Sleep Disorder, Circadian Dysregulation
Interventions: Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C), Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C), Usual Care Delayed Treatment; Behavioral · Other
Lead sponsor: University of California, Berkeley; Other
Eligibility: 18 Years and older
Enrollment: 489 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 10
States / cities: Concord, California • Fairfield, California • Goleta, California + 7 more

Conditions: Dementia, Telemedicine, Cognitive Dysfunction
Interventions: Not listed
Lead sponsor: Theodore Malmstrom, PhD; Other
Eligibility: 18 Years to 90 Years
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Attention-Deficit/Hyperactivity Disorder, Attention Deficit Disorder, Insomnia, Sleep Disorders
Interventions: Guanfacine extended-release tablets, Placebo comparator; Drug
Lead sponsor: Children's Specialized Hospital; Other
Eligibility: 6 Years to 12 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 2
States / cities: Hamilton, New Jersey • Toms River, New Jersey

Conditions: Low Back Pain
Interventions: Embedded Emergency Department Physical Therapy, Usual Care; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Chicago, Illinois • Salt Lake City, Utah

Conditions: Nonfluent Aphasia, Stroke
Interventions: levodopa/carbidopa, Placebo comparator; Drug
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 21 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Brain Metastases
Interventions: Temozolomide; Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Depression, Stress, Psychological, Self Efficacy, Loneliness, Social Isolation, Health Care Utilization, Dementia, Dementia Alzheimers, Dementia of Alzheimer Type, Dementia, Vascular, Dementia Frontal, Dementia, Lewy Body, Dementia, Mixed, Dementia in Parkinsons Disease, Dementia, HIV, Dementia Frontotemporal, Dementia, Multi-Infarct
Interventions: Building Better Caregivers Workshop, Attention Control; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 418 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Angelman Syndrome
Interventions: rugonersen, Sham procedure; Drug · Procedure
Lead sponsor: OHB Pediatrics Ltd.; Industry
Eligibility: 1 Year to 50 Years
Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 7
States / cities: Los Angeles, California • San Diego, California • Aurora, Colorado + 4 more

Conditions: Bowel Dysfunction, Constipation
Interventions: Alvimopan, Placebo; Drug
Lead sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA); Industry
Eligibility: 18 Years and older
Enrollment: 805 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 143
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 120 more

Conditions: Epilepsy
Interventions: Intraoperative brain microdialysis; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 45 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Delirium, Lumbar Radiculopathy, Lumbar Osteoarthritis, Lumbar Spine Disc Degeneration
Interventions: Light sedation with propofol, Induction with propofol, Maintenance anesthetic using a volatile anesthetic, Muscle relaxant during maintenance anesthesia, Pain control with fentanyl, Bispectral Index (BIS) monitoring for depth of anesthesia, Spinal Anesthesia, Midazolam administered during spinal anesthesia, Cerebrospinal fluid collection, Administration of intrathecal morphine; Procedure
Lead sponsor: Johns Hopkins University; Other
Eligibility: 65 Years and older
Enrollment: 218 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Multiple Sclerosis
Interventions: donepezil, glucose; Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 18 Years to 56 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2002
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Postoperative Pain
Interventions: HTX-011, Luer Lock applicator, Vial access device, aprepitant; Drug · Device
Lead sponsor: Heron Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Obsessive-Compulsive Disorder
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 4 Years to 12 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2010
U.S. locations: 4
States / cities: Little Rock, Arkansas • Gainesville, Florida • New York, New York + 1 more

Search by objective public record fields.

Cognitive Status After Removal of Skull Base Meningioma

Relationship of Dopamine to Cognitive Function in Parkinson's Disease

A Nutritional Intervention for Arthritis

TPAD for Recovery of Standing After Severe SCI

Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)

Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)

"SMART-FM": Smart-Phone Based Digital Therapeutic for Management of Fibromyalgia

Effects of Intensity of Early Communication Intervention

Carbamazepine for the Treatment of Chronic Post-Traumatic Brain Injury Irritability and Aggression

Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma

Implementing and Sustaining a Sleep Treatment to Improve Community Mental Part 1: Implementation Health Outcomes

EpxCogScreen -- A Phone-based Rapid Cognitive Screen (RCS)

Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia

A Multi-Site Feasibility Trial of Embedded Emergency Department Physical Therapy

Augmenting Language Therapy for Aphasia: Levodopa

Study of Temozolomide to Treat Newly Diagnosed Brain Metastases

Rural Dementia Caregiver Project

BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.

Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain

Intraoperative Brain Microdialysis to Assess Neuroinflammation in Epileptic Tissue Immediately Prior to Surgical Resection.

Shaping Anesthetic Techniques to Reduce Post-operative Delirium

Improving Memory in Patients With Multiple Sclerosis

Phase 2 Bunionectomy HTX-011 Administration Study

Characterization of Childhood-Onset Obsessive-Compulsive Disorder